ËÑË÷

»ùÒòÇÃÈëϸ°û

ÇÃÈëϸ°ûϵÊÇͨ¹ýÔÚÄ¿µÄ»ùÒòµÄÌØ¶¨Î»µã¾«×¼²åÈëÍâÔ´ DNA Ƭ¶Ï£¨ÈçÓ«¹â±êÇ©¡¢±¨¸æ»ùÒò»òÖ²¡Í»±äÐòÁУ©£¬£¬£¬ÔÚ¼á³Ö»ùÒò×ÔÈ»µ÷¿ØÇéÐεÄͬʱ£¬£¬£¬ÊµÏÖ¶Ô»ùÒò¹¦Ð§ºÍÂѰױí´ïµÄ¿É¿ØÐÞÊΡ£¡£¡£Ïà±ÈÓڹŰå¹ý±í´ïϵͳ£¬£¬£¬ÇÃÈëÄ£×ÓÄܸüÕæÊµµØ·´Ó¦ÄÚÔ´ÐÔ»ùÒòµÄ±í´ïˮƽºÍµ÷¿Ø»úÖÆ£¬£¬£¬ÊÇÑо¿ »ùÒò¹¦Ð§¡¢¼²²¡»úÖÆºÍÒ©Îï×÷Óà µÄÖ÷Òª¹¤¾ß¡£¡£¡£

ÍêÃÀÕæÈËÒÀÍÐ×ÔÖ÷ÓÅ»¯µÄ CRISPR/Cas9 Óë HDR ¼¼Êõƽ̨£¬£¬£¬Á¬Ïµ¸ßЧͬԴ±ÛÉè¼ÆÓëµ¥¿Ë¡ɸѡÁ÷³Ì£¬£¬£¬Îª¿Í»§Ìṩ¶¨ÖÆ»¯ÇÃÈëϸ°ûϵЧÀÍ¡£¡£¡£ÍêÃÀÕæÈ˼ƻ®¾ßÓÐ ¸ßЧÂÊ¡¢µÍÍѰÐÂÊ¡¢ÑéÖ¤ÖÜÈ« µÈÓÅÊÆ£¬£¬£¬È·±£»£»£»£»£»£»ñµÃÎȹ̿ɿ¿µÄϸ°ûÄ£×Ó¡£¡£¡£

ЧÀÍÏêÇé

ϸ°ûÀàÐÍ ÖÖÖÖϸ°ûÀàÐÍ£¬£¬£¬°üÀ¨Ö×Áö¡¢Í¨Àý¡¢¸Éϸ°û¡¢Ô­´úºÍÓÀÉú»¯Ï¸°ûϵ¡£¡£¡£
ЧÀÍÀàÐÍ Ó«¹âÂѰ׶¨µãÇÃÈ루EFGP¡¢Luc¡¢mCherryµÈ£©/ ±êÇ©ÂѰ׶¨µãÇÃÈ루Flag¡¢HA¡¢Myc¡¢HiBiTµÈ£©/ Ä¿µÄ»ùÒòÌØ¶¨Î»µãÇÃÈë / »ùÒòµãÍ»±ä
½»¸¶±ê×¼ »ùÒòÇÃÈëµ¥¿Ë¡ϸ°û1Ö꣨2¹Üϸ°û£¬£¬£¬1¡Á10^6/¹Ü£©
ÖÜÆÚ/¼ÛÇ® ¿ìÖÁ8ÖÜ£¬£¬£¬16800ÔªÆð ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾? ÔÚÏß×Éѯ

¼¼ÊõÔ­Àí

ÍêÃÀÕæÈË»ýÔÜÊ®¼¸ÄêµÄ»ùÒò±à¼­ÂÄÀú£¬£¬£¬½¨Éè4ÖÖ»ùÒòÇÃÈë¼¼Êõ£¬£¬£¬°üÀ¨£ºHES-KI¡¢CRISPaint¡¢Bingo™ºÍCRISPR/HDR£¬£¬£¬Öª×ãÖÖÖÖ»ùÒòÇÃÈëÐèÇ󣬣¬£¬ÊµÏÖЧÂÊÓ뾫׼¶ÈµÄË«ÖØÍ»ÆÆ£¬£¬£¬ÎªÄúɨƽ»ùÒòÇÃÈëϸ°û¹¹½¨µÄÕϰ­¡£¡£¡£
¼¼ÊõÀàÐÍ Ð§ÂÊ Óŵã ÊÊÓó¡¾°  
CRISPR/HDR 5-30% ÎÞаÐԸߣ¬£¬£¬Ö§³ÖµãÍ»±äºÍƬ¶Ï²åÈë ÆÆËé½Ï»îԾϸ°û

CRISPR/HDR¼¼ÊõÔ­Àí

CRISPR/HDRÊÇÒ»ÖÖÒÀÀµCRISPRϵͳºÍϸ°ûHDRÐÞ¸´»úÖÆÊµÏÖ»ùÒòÇÃÈëµÄ»ùÒò±à¼­¼¼Êõ¡£¡£¡£sgRNAʶ±ð²¢Á¬ÏµÄ¿µÄ»ùÒòλµã£¬£¬£¬ÔÚCas9ºËËáøµÄ×÷ÓÃÏÂÇиîDNAË«Á´£¬£¬£¬º¬Í¬Ô´±ÛµÄDNA¹©ÌåÄ£°åÔÚϸ°ûHDRÐÞ¸´»úÖÆµÄ×÷ÓÃÏ£¬£¬£¬ÕûºÏÖÁsgRNAÇиîλµãÖУ¬£¬£¬ÊµÏÖ׼ȷµÄ»ùÒòÇÃÈë¡£¡£¡£

 

CRISPR/HDR¼¼ÊõÓÅÊÆ

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
ÎÞаÐÔ¸ß
¿Éͨ¹ýµ÷½âsgRNAºÍDonorÄ£°å£¬£¬£¬ÔÚ²î±ðλÖÃʵÏÖ¶ÔÍâÔ´»ùÒòÐòÁеÄÇÃÈë
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
¾«×¼¶È¸ß
pegRNAЯ´øµÄ±à¼­ÐÅϢȷ±£ÁËÇÃÈëÆ¬¶ÏµÄ׼ȷÐÔ£¬£¬£¬ïÔÌ­ÁËÍѰкͷÇÔ¤ÆÚ±à¼­

CRISPR/HDR¼¼ÊõÁ÷³Ì

CRISPR/HDR¼¼ÊõÁ÷³Ì

CRISPaint 20-50% ²»ÒÀÀµÏ¸°ûÖÜÆÚ ÆÆËéÖÜÆÚ³¤µÄϸ°û

CRISPaint¼¼ÊõÔ­Àí

CRISPaintÊÇÒ»ÖÖ»ùÓÚCRISPR-Cas9ϵͳµÄ»ùÒòÇÃÈë¼¼Êõ£¬£¬£¬Í¨¹ýʹÓÃϸ°û×ÔÉíµÄ·ÇͬԴ×îºóÅþÁ¬£¨NHEJ£©ÐÞ¸´»úÖÆ£¬£¬£¬Äܹ»ÔÚÖ¸¶¨µÄ»ùÒòC¶ËλÖÃÇÃÈëÍâÔ´DNAƬ¶Ï£¬£¬£¬ÎÞÐèÒÀÀµÍ¬Ô´ÖØ×飨HDR£©¡£¡£¡£CRISPaintµÄÉè¼Æ¾ßÓи߶ȵÄÎÞаÐÔ£¬£¬£¬ÊÊÓÃÓÚ¶àÖÖ»ùÒò¹¦Ð§Ñо¿ºÍ»ùÒò×é±à¼­Ó¦Óᣡ£¡£

1¡¢CRISPR-Cas9Ö¸µ¼µÄË«Á´¶ÏÁÑ£¨DSB£©
Target sgRNAÖÊÁ££ºÇиî»ùÒòÌØ¶¨Î»Ö㬣¬£¬µ¼ÖÂDNAË«Á´¶ÏÁÑ£¬£¬£¬¼¤»îϸ°ûµÄDNAÐÞ¸´»úÖÆ¡£¡£¡£


2¡¢Í¨ÓÃDonorÔØÌåÉè¼Æ
CRISPaintʹÓÃÒ»ÖÖͨÓõĹ©ÌåDNAÄ£°å£¬£¬£¬Í¨¹ýÒÔÏÂ×é·ÖʵÏÖCRISPaintϽµµÍé»îµÄÇÃÈë²ßÂÔ£º
Frame sgRNAÖÊÁ££ºÇиîDonorÖÊÁ££¬£¬£¬ÔÚϸ°ûÄÚÐγÉÏßÐÔ»¯Ä£°æ£»£»£»£»£»£»ÓÐ3ÖÖFrame-sgRNA¿É¹©Ñ¡Ôñ£¬£¬£¬°ü¹ÜÇÃÈë»ùÒò׼ȷOFRÐòÁбí´ï¡£¡£¡£
ͨÓÃDonorÖÊÁ££º°üÀ¨´ý²åÈëµÄ»ùÒòÐòÁУ¨ÈçÓ«¹âÂѰף©ºÍ3ÖÖDonor-sgRNAµÄ°ÐµãÐòÁС£¡£¡£

CRISPaint¼¼ÊõͨÓÃDonorÔØÌåÉè¼Æ

3¡¢·ÇͬԴ×îºóÅþÁ¬£¨NHEJ£©
°Ðµã»ùÒòÐγÉDSBºÍDonor±»Çи£¬£¬Ï¸°ûͨ¹ýNHEJÐÞ¸´»úÖÆ£¬£¬£¬½«ÏßÐÔ»¯µÄDonorÄ£°æÕûºÏÖÁDSBλÖ㬣¬£¬ÊµÏÖÁ˸ßЧµÄ»ùÒòÇÃÈë¡£¡£¡£

CRISPaint¼¼Êõ·ÇͬԴ×îºóÅþÁ¬£¨NHEJ£©

CRISPaint¼¼ÊõÓÅÊÆ

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
¸ßЧÐÔ
NHEJ½éµ¼»ùÒòÇÃÈ룬£¬£¬ÎÞÐèͬԴ±Û£¬£¬£¬²åÈëЧÂʸߴï50%
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
ÊÊÓùæÄ£¹ã
²»ÒÀÀµÓÚϸ°ûÆÆË飬£¬£¬ÊÊÓÃÓÚ¶àÖÖϸ°ûÀàÐÍ
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
ÎÞаÐÔ
ͨÓÃDonorÖÊÁ£°üÀ¨3ÖÖDonor-sgRNA°ÐµãÐòÁУ¬£¬£¬ÎÞаѡÔñFrame sgRNAÖÊÁ££¬£¬£¬ÊµÏÖ»ùÒòORFÐòÁÐ׼ȷÕûºÏ

CRISPaintʵÑéÁ÷³Ì

CRISPaintʵÑéÁ÷³Ì

BingoPE™ 30-80% ÎÞDSB»ò¹©ÌåÄ£°å£¬£¬£¬ÍѰÐΣº¦µÍ ¾«×¼ÇÃÈëСƬ¶Ï»òµãÍ»±äÐÞ¸´

Bingo™¼¼ÊõÔ­Àí

Bingo™ ÊÇÒ»ÖÖ»ùÓÚPrime Editing½éµ¼Ð¡Æ¬¶ÏÇÃÈëµÄ»ùÒò±à¼­¼¼Êõ£¬£¬£¬Äܹ»ÔÚ²»ÒÀÀµDNAË«Á´¶ÏÁѵÄÇéÐÎÏ£¬£¬£¬ÊµÏÖ¶ÔÄ¿µÄ»ùÒòµÄ¾«×¼±à¼­¡£¡£¡£¸Ã¼¼ÊõµÄ½¹µãÔÚÓÚʹÓÃÈÚºÏÁËÄæ×ªÂ¼Ã¸µÄCas9 nickase£¨Cas9n-RT£©£¬£¬£¬ÔÚpegRNAÖ¸µ¼ÏÂʶ±ð±à¼­Î»µã£¬£¬£¬Í¨¹ýCas9nÔڱ༭λµã±¬·¢µ¥Á´ÇпÚ£¬£¬£¬Äæ×ªÂ¼Ã¸Ê¹ÓÃpegRNAµÄÄ£°åÐòÁÐÔÚµ¥Á´ÇпÚλÖúϳÉеÄDNAÐòÁУ¬£¬£¬´Ó¶øÊµÏÖ¾«×¼µÄ»ùÒòÇÃÈë¡£¡£¡£

 

Bingo™¼¼ÊõÓÅÊÆ

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
¸üÇå¾²
PE¼¼Êõͨ¹ýµ¥Á´ÇиîʵÏֱ༭£¬£¬£¬×èÖ¹ÁËDSB´øÀ´µÄ²»ÎȹÌÐÔ£¬£¬£¬ÏÔÖøÌá¸ßÁ˱༭µÄÇå¾²ÐÔ
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
¸ß׼ȷÐÔ
pegRNAЯ´øµÄ±à¼­ÐÅϢȷ±£ÁËÇÃÈëÆ¬¶ÏµÄ׼ȷÐÔ£¬£¬£¬ïÔÌ­ÁËÍѰкͷÇÔ¤ÆÚ±à¼­
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
¶à¹¦Ð§ÐÔ
Äܹ»ÊµÏÖСƬ¶ÏDNAµÄ²åÈ루ÈçÖÕÖ¹ÃÜÂë×Ó¡¢±êÇ©ÐòÁеȣ©£¬£¬£¬ÊÊÓÃÓÚ¶àÖÖ»ùÒò×é±à¼­ÐèÇó

Bingo™ÊµÑéÁ÷³Ì

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

HES-KI 40%-90% ÆæÒìɸѡ»úÖÆ½éµ¼¸ßЧÇÃÈë Ö÷Òª»ùÒòλµãC¶ËÇÃÈë

HES-KI¼¼ÊõÔ­Àí

HES-KI£¨Ö÷Òª»ùÒòλµãÇÃÈ룩ÊÇÒ»ÖÖÐÂÐ͵ÄÇÃÈë¼¼Êõ£¬£¬£¬Í¨¹ýÔÚÖ÷Òª»ùÒòµÄC¶ËÍâÏÔ×ÓÇøÓò¾ÙÐÐCRISPR±à¼­£¬£¬£¬²¢Éè¼ÆÒ»¸öת»ùÒòÇÃÈëÄ£°å£¬£¬£¬Ê¹µÃÀÖ³ÉÇÃÈëµÄϸ°ûÄܹ»»Ö¸´Ö÷Òª»ùÒòµÄ¹¦Ð§£¬£¬£¬Í¬Ê±ÕûºÏÇÃÈëµÄ»ùÒòÐòÁУ»£»£»£»£»£»ÈôÊÇδÀÖ³ÉÇÃÈëϸ°û£¬£¬£¬ÈçNHEJ½éµ¼µÄÓвåÈë»òȱʧ£¨indels£©µÄϸ°û£¬£¬£¬½«µ¼ÖÂÖ÷Òª»ùÒò¹¦Ð§Ëðʧ£¬£¬£¬Ê¹Ï¸°ûÎÞ·¨´æ»î£¬£¬£¬´Ó¶øÊµÏÖ¶ÔÀÖ³ÉÇÃÈëϸ°ûµÄ¸»¼¯¡£¡£¡£

HES-KI¼¼ÊõÓÅÊÆ

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
¸ßЧÂÊ
ͨ¹ýÕýÏòÑ¡Ôñ»úÖÆ£¬£¬£¬×èÖ¹·ÇÌØÒìÐÔÇÃÈ룬£¬£¬Ìá¸ßÇÃÈëЧÂÊ£¬£¬£¬ÔÚ¶àÖÖϸ°ûÀàÐÍÖÐʵÏָߴï68%µÄÇÃÈëЧÂÊ£¬£¬£¬Ô¶³¬¹Å°å¼¼Êõ
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
ÎȹÌÇÒ¾ùÒ»
ÇÃÈëµ¥¿Ë¡ϸ°ûÖÐÄ¿µÄ»ùÒò±í´ïÎȹÌÇÒ¾ùÒ»
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
¶à»ùÒòÕûºÏ
¿ÉͬʱÇÃÈë¶à¸ö»ùÒò£¬£¬£¬ÀýÈ磬£¬£¬ÇÃÈë¶à¸öCAR»ùÒò£¬£¬£¬ÖÜÈ«°ÐÏò¶àÖÖÖ×Áö¿¹Ô­£¬£¬£¬ïÔÌ­Ö×ÁöÌÓÒÝ
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
µ÷¿ØÄÜÁ¦Ç¿
ͨ¹ýÑ¡Ôñ²î±ðµÄÖ÷Òª»ùÒò£¬£¬£¬¿ÉÎÞаµ÷½âÄ¿µÄ»ùÒò±í´ïˮƽ

HES-KI¼¼ÊõÁ÷³Ì

HES-KI¼¼ÊõÁ÷³Ì

Àֳɰ¸Àý

±¾°¸Àý½ÓÄÉAsCas12aºËÌǺËÂѰף¨RNP£©ÓëEGFP¹©ÌåÖÊÁ£¹²×ªÈ¾K562ϸ°û£¬£¬£¬Í¨¹ýHES-KI£¨¸ßЧÇÃÈ룩²ßÂÔʵÏÖÁËEGFP»ùÒòµÄ¶¨µãÕûºÏ¡£¡£¡£ÔÚδʹÓÿ¹ÐÔɸѡµÄÌõ¼þÏ£¬£¬£¬¶à¿Ë¡ϸ°ûµÄÇÃÈëЧÂʵִï37%£¬£¬£¬ÇÒEGFPµÄ²åÈëδ¶Ôϸ°ûÉú³¤±¬·¢ÏÔ×ÅÓ°Ïì¡£¡£¡£½øÒ»²½½¨ÉèµÄµ¥¿Ë¡ϸ°ûÖê¾­Ò»Á¬15´ú´«´ú×÷Óýºó£¬£¬£¬EGFP mRNAÈÔ¼á³ÖÎȹ̱í´ï£¬£¬£¬Åú×¢»ùÒòÕûºÏЧ¹û³¤ÆÚ¿É¿¿£¬£¬£¬ÊµÑéЧ¹ûÈçÏ£º
¢Ù ¶à¿Ë¡ϸ°ûµÄÇÃÈëЧÂʵִï37%
K562ϸ°û
EGFP»ùÒòÇÃÈëK562ϸ°û
¢Ú K562 EGFP-KIϸ°ûºÍWTϸ°ûµ¥¿Ë¡ϸ°ûÖê±¶Ôöʱ¼ä²î±ð²»ÏÔÖø£¬£¬£¬EGFP²åÈëºó²»Ó°ÏìK562ϸ°ûÉú³¤¡£¡£¡£
EGFP²åÈëºó²»Ó°ÏìK562ϸ°ûÉú³¤
¢Û ²î±ðK562 EGFP-KIµ¥¿Ë¡ϸ°ûÖêEGFP mRNA±í´ïÁ¿²î±ð²»ÏÔÖø£¬£¬£¬EGFP-KIµ¥¿Ë¡¾ùÒ»ÐԺᣡ£¡£
EGFP-KIµ¥¿Ë¡¾ùÒ»ÐÔºÃ
¢Ü K562 EGFP-KI²î±ðµ¥¿Ë¡ϸ°ûÖê¾­ÓÉ15´ú´«´ú×÷Óý£¬£¬£¬EGFP mRNA±í´ïÁ¿ÎȹÌ
EGFP mRNA±í´ïÁ¿ÎȹÌ
±¾°¸Àý½ÓÄÉCRISPR/Cas9ºËÌǺËÂѰף¨RNP£©ÓëEGFP¹©ÌåÖÊÁ£¹²×ªÈ¾CHO-K1ϸ°û/293T£¬£¬£¬Í¨¹ýHES-KI£¨¸ßЧÇÃÈ룩²ßÂÔʵÏÖÁËEGFP»ùÒòµÄ¶¨µãÕûºÏ¡£¡£¡£ÔÚδʹÓÿ¹ÐÔɸѡµÄÌõ¼þÏ£¬£¬£¬¶à¿Ë¡ϸ°ûµÄÇÃÈëЧÂʵִï55%£¬£¬£¬293Tϸ°û¶à¿Ë¡ϸ°ûµÄÇÃÈëЧÂʵִï68%ÇÒEGFPµÄ²åÈëδ¶Ôϸ°ûÉú³¤±¬·¢ÏÔ×ÅÓ°Ïì¡£¡£¡£
¢Ù ¶à¿Ë¡ϸ°ûµÄÇÃÈëЧÂÊ
293T CHO-K1
293T
CHO-K1
293T-EGFP
CHO-K1-EGFP
¢ÚËæ×Å´«´ú´ÎÊýÔöÌí£¬£¬£¬CHO-K1/293T-EGFPϸ°ûEGFP mRNA±í´ïÁ¿¼á³ÖÎȹ̱í´ï
CHO-K1/293T-EGFPϸ°ûEGFP mRNA±í´ïÁ¿¼á³ÖÎȹ̱í´ï
»ùÓÚÍêÃÀÕæÈËbingoƽ̨£¬£¬£¬Éè¼ÆÏà¹ØÎ»µãµÄpegRNA,nick sgRNA,²âÐò²¢ÑéÖ¤ÖÊÁ£ÐòÁеÄ׼ȷÐÔ£¬£¬£¬Í¨¹ýÖÊÁ££¨¸¨ÖúÖÊÁ£ÒÔ¼°pegRNA,nick sgRNA£©Ë²×ªÈëϸ°û£¬£¬£¬ÌáÈ¡»ùÒò×é²¢Ñé֤λµãÍ»±äÇéÐÎ
ϸ°ûÀàÐÍ cell pool ±à¼­Ð§ÂÊ ²âÐò·åͼ ÌôÑ¡µ¥¿Ë¡ÊýÄ¿ µ¥¿Ë¡´¿ºÏ×ÓÊýÄ¿
Hela 64% WT:TCCGCTACCACCAATGCCTAATGCATTTGG
MT:TCCGCTACCACCAATGCTAATAACTAATGCATTTGG
ʹÓÃÏȵ¼±à¼­ÔÚHelaϸ°ûÖй¹½¨¼î»ù²åÈëϸ°ûϵ²âÐò·åͼ
11 1

 

Advantage and Characteristic

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
Optimazied Strategy
We have create a unique sgRNA Design Logic
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
Optimazied Strategy
We have create a unique sgRNA Design Logic
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
Optimazied Strategy
We have create a unique sgRNA Design Logic
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
Optimazied Strategy
We have create a unique sgRNA Design Logic

²Î¿¼ÎÄÏ×

Modulation of cell cycle increases CRISPR-mediated homology-directed DNA repair

¸ÃÑо¿Ì½ÌÖÁËͨ¹ýͬ²½Ï¸°ûÖÜÆÚÀ´ÔöÇ¿CRISPR½éµ¼µÄÍ¬Ô´ÖØ×éÐÞ¸´£¨HDR£©Ð§ÂʵÄÒªÁì¡£¡£¡£Ê¹ÓÃС·Ö×Óµ÷Àíϸ°ûÖÜÆÚ£¬£¬£¬ÔÚÖÖÖÖϸ°ûϵÖÐʵÏÖÁË1.2-1.5±¶µÄKIЧÂÊÌá¸ß¡£¡£¡£Ñо¿»¹Õ¹Ê¾Á˸ÃÒªÁìÔÚ¶¯ÎïÅßÌ¥ÖеÄÓ¦Ó㬣¬£¬ÏÔÖøÌá¸ßÁËÖíÅßÌ¥ÖеÄKIƵÂÊ¡£¡£¡£ÕâÒ»ÒªÁìͨ¹ýµ÷Àíϸ°û½øÈëÓÐÀûÓÚHDRµÄÖÜÆÚ½×¶Î£¬£¬£¬´Ó¶øÌá¸ßÁË»ùÒòÇÃÈëµÄÀÖ³ÉÂÊ£¬£¬£¬ÎªCRISPR»ùÒò±à¼­ÌṩÁËеÄÓÅ»¯²ßÂÔ¡£¡£¡£

CLASH enables large-scale parallel knock-in for cell engineering

CLASH£¨Cas9-Linked Adaptor Synthesis for Homology-directed repair£©¼¼ÊõÄܹ»ÔÚ´ó¹æÄ£Ï¸°û¹¤³ÌÖÐʵÏÖ¸ßЧµÄ»ùÒòÇÃÈë¡£¡£¡£¸ÃÒªÁìÁ¬ÏµÁËCas9ÂѰ׺ÍÊÊÅä×ӺϳÉ£¬£¬£¬Ê¹µÃÔÚ¶àÖÖϸ°ûÀàÐÍÖоÙÐÐÆ½ÐÐÇÃÈë³ÉΪ¿ÉÄÜ¡£¡£¡£Í¨¹ýÔÚDNAÐÞ¸´Àú³ÌÖÐÌá¹©ÌØ¶¨µÄÊÊÅä×ÓÀ´Ìá¸ßÍ¬Ô´ÖØ×éÐÞ¸´£¨HDR£©µÄЧÂÊ£¬£¬£¬´Ó¶ø´ó´óÌáÉý»ùÒòÇÃÈëµÄÀÖ³ÉÂÊ¡£¡£¡£¸Ã¼¼ÊõչʾÁËÔÚϸ°û¹¤³ÌºÍ»ùÒò±à¼­ÖеÄÖØ´óDZÁ¦£¬£¬£¬ÌØÊâÊÇÔÚÐèÒª¶à»ùÒòÐ޸ĵÄÖØ´óÉúÎ﹤³ÌÓ¦ÓÃÖС£¡£¡£

¾«Ñ¡¿Í»§ÎÄÕÂ

IF=50.5
nature

È«ÇòÁè¼ÝÒ»°ëµÄ¸Îϸ°û°©£¨HCC£©²¡Àý±¬·¢ÔÚÖйú£¬£¬£¬µ«ÏÖÔÚÕë¶ÔÖйúÈËȺÖÐÒÒÐ͸ÎÑײ¡¶¾£¨HBV£©Ïà¹ØHCCµÄÈ«»ùÒò×éÆÊÎöÑо¿ºÜÊÇÓÐÏÞ¡£¡£¡£ÎªÁËÍ»ÆÆÕâÖÖÏÞÖÆ£¬£¬£¬Ñо¿Ö°Ô±Æô¶¯ÁË“Öйú¸Î°©Í¼Æ×ÏîÄ¿”£¨CLCA£©£¬£¬£¬Ö¼ÔÚ¶ÔÖйúÈËȺÖеÄHCC¾ÙÐдó¹æÄ£µÄÈ«»ùÒò×éÆÊÎöÒÔÃ÷È·ÆäÆæÒìµÄ·¢²¡»úÖÆºÍ½ø»¯Àú³Ì¡£¡£¡£¸ÃÏîÄ¿¶Ô494ÀýHCCÖ×ÁöÑù±¾¾ÙÐÐÁËÉî¶ÈÈ«»ùÒò×é²âÐò£¨Æ½¾ù²âÐòÉî¶ÈΪ120×£©£¬£¬£¬²¢ÆÊÎöÁËÆ¥ÅäµÄ±ÈÕÕѪҺÑù±¾£¬£¬£¬Õ¹ÏÖÁËHBVÏà¹ØHCCµÄÏêϸ»ùÒò×éÌØÕ÷¡£¡£¡£Ñо¿·¢Ã÷£¬£¬£¬³ýÁËÒÑÖªµÄ±àÂëÇøÇý¶¯»ùÒò£¨ÈçTP53ºÍCTNNB1£©Í⣬£¬£¬»¹±£´æ6¸öеıàÂëÇøÇý¶¯»ùÒò£¨°üÀ¨FGA£©ºÍ31¸ö·Ç±àÂëÇøÇý¶¯»ùÒò¡£¡£¡£±ðµÄ£¬£¬£¬Ñо¿»¹Õ¹ÏÖ5ÖÖеÄÍ»±äÌØÕ÷£¨°üÀ¨SBS_H8£©£¬£¬£¬ÒÔ¼°HBVÕûºÏÐγÉϸ°ûÍâ»·×´DNA£¨ecDNA£©µÄÕ÷Ï󣬣¬£¬ÕâЩecDNA¿Éµ¼Ö°©»ùÒòÀ©ÔöºÍ±í´ïÔöÌí¡£¡£¡£Í¨¹ý¹¦Ð§Ñé֤ʵÑ飬£¬£¬Ñо¿Ö°Ô±Ö¤ÊµÁËFGA¡¢PPP1R12BºÍKCNJ12µÈ»ùÒòµÄÍ»±äÄܹ»ÏÔÖøÓ°ÏìHCCϸ°ûµÄÔöÖ³¡¢Ç¨áãºÍÇÖÏ®ÄÜÁ¦¡£¡£¡£ÕâÏîÑо¿Ð§¹û²»µ«¸»ºñÁËÈËÃǶÔHCC»ùÒò×éѧµÄÃ÷È·£¬£¬£¬Ò²ÎªHCCµÄÕï¶ÏºÍÖÎÁÆÌṩÁËеÄDZÔڰеã¡£¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ºòÑ¡Çý¶¯Òò×Ӹſö

IF=27.4
Advanced material

¼¡ëìËðÉ˼±ÐÔÑ×Ö¢ÆÚÖУ¬£¬£¬¾ÞÊÉϸ°ûÌ«¹ý¼¤»î»áµ¼Ö±àÂë¹ÇÇÅÂѰ×OPNµÄSPP1¹ý±í´ï£¬£¬£¬Ó°Ïì×éÖ¯ÔÙÉú¡£¡£¡£CRISPR-Cas13ÓÉÓÚ¾ßÓÐRNA±à¼­ºÍ¿ìËÙ½µ½âµÄÄÜÁ¦£¬£¬£¬ÔÚ×éÖ¯ÐÞ¸´·½Ãæ¾ßÓÐÖØ´óDZÁ¦£¬£¬£¬µ«È±·¦ºÏÊÊÓÐÓõĵÝËÍÒªÁì¡£¡£¡£¶Ô´Ë£¬£¬£¬Ñо¿Ö°Ô±ÏµÍ³É¸Ñ¡ÁËÕë¶Ô¾ÞÊÉϸ°ûµÄÑôÀë×Ó¾ÛºÏÎ£¬£¬¿ª·¢ÁËÒ»ÖÖÄܹ»¸ßЧµÝËÍCas13ºËÌǺËÂѰ׸´ºÏÎCas13 RNP£©½øÈë¾ÞÊÉϸ°ûµÄÄÉÃ×´ØÔØÌå¡£¡£¡£Í¨¹ý·´Ó¦ÐÔÑõÖÖ£¨ROS£©ÏìÓ¦ÐÔÊÍ·Å»úÖÆ£¬£¬£¬¸ÃϵͳÄܹ»ÔÚ¼¡ëìËðÉ˵ļ±ÐÔÑ×֢΢ÇéÐÎÖÐÌØÒìÐÔÒÖÖÆ¾ÞÊÉϸ°ûÖÐSPP1µÄ¹ý±í´ï¡£¡£¡£ÊµÑéЧ¹ûÅú×¢£¬£¬£¬ÕâÖÖ°ÐÏò²ßÂÔÏÔÖøïÔÌ­ÁËËðÉËÓÕµ¼µÄSPP1±¬·¢¾ÞÊÉϸ°ûµÄ·ºÆð£¬£¬£¬½µµÍÁ˳ÉÏËάϸ°ûµÄ¼¤»î£¬£¬£¬²¢¼õÇáÁ˼¡ëìÖÜΧµÄÕ³Á¬ÐγÉ¡£¡£¡£±ðµÄ£¬£¬£¬¸ÃÑо¿»¹Õ¹ÏÖÁËSPP1ͨ¹ýCD44/AKTÐźÅͨ·Ôö½ø³ÉÏËάϸ°û»î»¯ºÍǨáãµÄ»úÖÆ£¬£¬£¬²¢Í¨¹ýÒÖÖÆÕâһͨ·ÓÐÓûº½âÁ˼¡ëìËðÉ˺óµÄÕ³Á¬ÎÊÌâ¡£¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ÓÃÓÚPAÖÎÁƵľÞÊÉϸ°ûÃâÒß΢ÇéÐ줻îmRNA±à¼­²ßÂÔµÄʾÒâͼ

IF=12.8
Biomaterials

¼¹ËèËðÉË£¨SCI£©ÊÇÒ»ÖÖµ¼Ö¸ÐÊÜ×ÔÖ÷Éñ¾­ºÍÔ˶¯¹¦Ð§µÄÓÀÊÀÐÔË𺦵ÄÑÏÖØÖ²ÐÐÔ¼²²¡¡£¡£¡£¸Éϸ°ûÁÆ·¨£¬£¬£¬ÓÈÆäÊǼä³äÖʸÉϸ°û£¨MSCs£©£¬£¬£¬ÔÚSCIÖÎÁÆÖÐÕ¹ÏÖ³öÖØ´óDZÁ¦µ«ÆäÔÙÉúÄÜÁ¦ÓÐÏÞ£¬£¬£¬ÕâÏÞÖÆÁËÆäÔÚ×éÖ¯ÔÙÉúÖеÄÓ¦Óᣡ£¡£Ñо¿ÍŶÓÊӲ쵽ABPCsÑÜÉúµÄEVs£¨EVsABPC£©¿ÉÄÜЯ´øÔö½ø×éÖ¯ÔÙÉúµÄÉúÎï»îÐÔÐźÅ£¬£¬£¬Òò´ËËûÃÇ´Ó¹½ÇÑ¿»ù×æÏ¸°û£¨ABPCs£©ÖÐÌáÈ¡²¢ÐÞÊÎÁËϸ°ûÍâÄÒÅÝ£¨EVsABPC£©£¬£¬£¬²¢½«ÆäÓ¦ÓÃÓÚ¼¹ËèËðÉË£¨SCI£©µÄÖÎÁÆÑо¿¡£¡£¡£Ñо¿Ö°Ô±·¢Ã÷EVsABPCÄܹ»ÏÔÖøÔöÇ¿Éñ¾­¸Éϸ°û£¨NSCs£©µÄÔöÖ³£¬£¬£¬Ôö½øÖáÍ»Éú³¤£¬£¬£¬ïÔÌ­Éñ¾­ÔªµòÍö£¬£¬£¬²¢Í¨¹ýµ÷ÀíÑ×Ö¢·´Ó¦½«¾ÞÊÉϸ°û´Ó´ÙÑ×µÄM1Ðͼ«»¯Îª¿¹Ñ×µÄM2ÐÍ¡£¡£¡£±ðµÄ£¬£¬£¬¾­Óɹ¤³Ì»¯Ë¢ÐµÄEVsABPC£¨Í¨¹ý¼¤»îϸ°û´©Í¸ëÄÐÞÊΣ©Äܹ»¸üÓÐÓõذÐÏòSCIËðÉ˲¿Î»£¬£¬£¬ÏÔÖø¸ÄÉÆÉñ¾­ÔÙÉúºÍÔ˶¯¹¦Ð§»Ö¸´¡£¡£¡£ÕâЩЧ¹ûÅú×¢£¬£¬£¬EVsABPCÊÇÒ»ÖÖ¼«¾ßDZÁ¦µÄSCIÖÎÁƺòÑ¡¼Æ»®¡£¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ͼ½âÕªÒª

IF=12.2
Journal of Hazardous Materials

S-Òì±û¼×²Ý°·£¨S-MET£©ÊÇÎÒ¹úÉú²úºÍʹÓÃÁ¿×î´óµÄ³ý²Ý¼ÁÖ®Ò»£¬£¬£¬Æä»¯Ñ§ÌØÕ÷µ¼ÖÂÆä¿ÉÔÚÍÁÈÀÖг¤ÆÚ±£´æÒÔ¼°ÈÝÒ×ͨ¹ýÁÜÈܺͳÁ½µÎÛȾµØ±íË®ºÍµØÏÂË®£¬£¬£¬×îÖÕÓ°ÏìÖ²ÎïÉú³¤ºÍͨ¹ýʳÎïÁ´Î£º¦ÈËÀàÉúÃü¿µ½¡¡£¡£¡£¼øÓÚÏÖÓмì²âÒªÁìµÄ¾ÖÏÞÐԺͶԸßЧÆÊÎö¼¼ÊõµÄÆÈÇÐÐèÇ󣬣¬£¬¸ÃÑо¿ÒÔS-metolachlorΪ¹¤¾ß£¬£¬£¬Ê¹Óò¸È鶯Îï±í´ïϵͳÌìÉúÏà¹ØÖØ×鿹Ìå¡£¡£¡£ÔÚÀֳɱí´ï¿¹ÌåµÄ»ù´¡ÉÏ£¬£¬£¬Àֳɽ¨ÉèÁË»ùÓÚÕâЩ¿¹ÌåµÄÃâÒ߯ÊÎöÒªÁ죬£¬£¬ÓÃÓÚ¼à²âÇéÐÎË®ÑùÖеÄS-Òì±û¼×²Ý°·²ÐÁô¡£¡£¡£icELISAЧ¹ûÏÔʾ£¬£¬£¬ÖØ×鿹ÌåµÄѸËٶȺÍÌØÒìÐÔÓëÇ×±¾µ¥¿¹ÏàËÆ£¬£¬£¬¿É¼á³ÖÔ­ÓеÄÉúÎïѧ»îÐÔ£¬£¬£¬¹ØÓÚ½­Ë®¡¢Å©ÌïË®ºÍ×ÔÀ´Ë®ÖеÄS-MET£¬£¬£¬¾ßÓÐÓÅÒìµÄ׼ȷÐÔºÍÖØ¸´ÐÔ¡£¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ͼ½âÕªÒª

IF=10.7
Biosensors and Bioelectronics

ϸСRNA£¨miRNA£©ÊÇÒ»ÀàСµÄ·Ç±àÂëRNA·Ö×Ó£¬£¬£¬Í¨¹ýÓëÌØ¶¨°Ð»ùÒòµÄÐÅʹRNA£¨mRNA£©Ï໥×÷ÓÃÀ´µ÷¿Ø»ùÒò±í´ï¡£¡£¡£miRNAÔÚ¶àÖÖ¼²²¡µÄ±¬·¢¡¢Éú³¤Àú³ÌÖÐÊÎÑÝ×ÅÖ÷Òª½ÇÉ«£¬£¬£¬±»ÒÔΪÊǼ«¾ßDZÁ¦µÄ¼²²¡ÉúÎï±ê¼ÇÎï¡£¡£¡£¸ÃÑо¿Ê¹ÓÃCRISPR/Cas12a¿ª·¢ÁËÒ»ÖÖΪDBmRCAµÄÐÂÐÍmiRNA¼ì²â¼¼Êõ¡£¡£¡£¸Ã¼¼ÊõʹÓÃÎÞÅþÁ¬Ã¸µÄÑÆÁå̽ÕëºÍ¸ßѸËٶȵÄCRISPR/Cas12aÐźÅÊä³ö²ßÂÔ£¬£¬£¬ÊµÏÖÁËÔÚ30·ÖÖÓÄÚ¶ÔmiRNAµÄ¸ß¾«¶È¶¨Á¿ÆÊÎö¡£¡£¡£Ñо¿ÍŶÓͨ¹ýÁÙ´²Ñù±¾ÑéÖ¤Á˸ü¼ÊõµÄÓÐÓÃÐÔ£¬£¬£¬·¢Ã÷miR-200aºÍmiR-126Ôڷΰ©×éÖ¯Öеıí´ïˮƽÏÔÖø½µµÍ£¬£¬£¬ÇҸü¼ÊõÓë¹Å°åÒªÁìЧ¹ûÒ»Ö¡£¡£¡£DBmRCA¼¼Êõ¾ßÓÐʱ¼äЧÂʸߡ¢Ñ¸ËÙ¶ÈÇ¿ºÍ²Ù×÷Á÷³Ì¼ò»¯µÈÓŵ㣬£¬£¬ÎªÁÙ´²miRNAÆÊÎöÌṩÁËÒ»ÖÖ¿É¿¿µÄ¹¤¾ß£¬£¬£¬ÓÐÍûÖúÁ¦·Î°©µÄÔçÆÚÕï¶ÏºÍÖÎÁÆ¡£¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ͼ½âÕªÒª

FAQ

»ùÒòÇÃÈëÔÚÒ©Î↑·¢ÖеÄ×÷ÓÃÊÇʲô?
»ùÒòÇÃÈëÔÚÒ©Î↑·¢ÖÐʩչÁËÖ÷Òª×÷Óᣡ£¡£ËüÓÃÓڰеãÑéÖ¤£¬£¬£¬Í¨¹ý½«Ìض¨»ùÒòÇÃÈëϸ°ûϵ»ò¶¯ÎïÄ£×ÓÖУ¬£¬£¬È·ÈÏÒ©Îï°ÐµãµÄÓÐÓÃÐÔ¡£¡£¡£Ëü»¹ÄÜ×ÊÖú½¨Éè¼²²¡Ä£×Ó£¬£¬£¬²âÊÔÒ©ÎïÔÚÕâЩģ×ÓÉϵÄÁÆÐ§ºÍÇå¾²ÐÔ¡£¡£¡£»£»£»£»£»£»ùÒòÇÃÈë¼¼Êõ»¹Ö§³ÖÒ©Îïɸѡ£¬£¬£¬Í¨¹ý´øÓÐÇÃÈë»ùÒòµÄϸ°ûϵ¾ÙÐиßͨÁ¿É¸Ñ¡£¬£¬£¬·¢Ã÷DZÔÚÒ©ÎïºòÑ¡·Ö×Ó¡£¡£¡£±ðµÄ£¬£¬£¬Ëü»¹ÄÜÕ¹ÏÖÒ©ÎïµÄ×÷ÓûúÖÆ£¬£¬£¬ÓÅ»¯Ò©Îï½á¹¹ºÍÓ÷¨¡£¡£¡£ÕûÌå¶øÑÔ£¬£¬£¬»ùÒòÇÃÈë¼¼Êõ¼ÓËÙÁËÒ©ÎïÑз¢Àú³Ì£¬£¬£¬²¢Ìá¸ßÁËÖÎÁÆÐ§¹ûºÍÇå¾²ÐÔ¡£¡£¡£
»ùÒòÇÃÈë¼¼ÊõÊÇͨ¹ý½«ÍâÔ´»ùÒòÐòÁвåÈëµ½»ùÒò×éµÄÌØ¶¨Î»ÖÃÀ´ÊµÏÖ»ùÒò¹¦Ð§Ñо¿¡£¡£¡£ÍêÃÀÕæÈËʹÓÃÏȽøµÄ»ùÒò±à¼­¹¤¾ß£¬£¬£¬ÈçCRISPR/Cas9ϵͳ£¬£¬£¬Í¨¹ýÖ¸µ¼ºËËáøÇиîÄ¿µÄDNA£¬£¬£¬²¢Ê¹ÓÃÍ¬Ô´ÖØ×é»ò·ÇͬԴ×îºóÅþÁ¬½«ÍâÔ´»ùÒò׼ȷ²åÈëÖ¸¶¨Î»Ö㬣¬£¬ÒÔʵÏÖ¸ßЧÇÒ׼ȷµÄ»ùÒòÇÃÈë¡£¡£¡£
ÍêÃÀÕæÈËÔÚ»ùÒòÇÃÈë¼¼ÊõÖеÄÖ÷ÒªÓÅÊÆ°üÀ¨£º
Ч¹û°ü¹Ü£ºÎÒÃÇÓµÓÐ10ÄêCRISPR»ùÒò±à¼­ÂÄÀú£¬£¬£¬È«Çò×ÅÃûԺУ²©Ê¿×¨¼ÒÍŶÓÒ»¶ÔһЧÀÍ¡£¡£¡£
¸ß¾«¶È£ºÊ¹ÓÃÍêÃÀÕæÈË¿ª·¢µÄÓÅ»¯¹¤¾ß£¬£¬£¬ïÔÌ­ÍѰÐЧӦ£¬£¬£¬Ìá¸ß±à¼­µÄ׼ȷÐÔ¡£¡£¡£
¸ßЧÂÊ£ºÍêÃÀÕæÈ˵ļ¼Êõƽ̨Ìá¸ßÁË»ùÒòÇÃÈëµÄÀÖ³ÉÂÊ£¬£¬£¬¼ÓËÙÁËʵÑéÀú³Ì¡£¡£¡£
¶¨ÖÆÐ§ÀÍ£ºÆ¾Ö¤¿Í»§ÐèÇ󣬣¬£¬Ìṩ¸öÐÔ»¯µÄ»ùÒòÇÃÈë½â¾ö¼Æ»®£¬£¬£¬ÒÔÖª×ã²î±ðÑо¿»òÖÎÁÆÄ¿µÄ¡£¡£¡£
ÁªÏµÍêÃÀÕæÈË
*
*
*
ȪԴ£º

ÁªÏµÍêÃÀÕæÈË

*
*
*
*
ȪԴ£º
»¶Ó­¶©ÔÄÎÒÃÇÓʼþÄÚÈÝ
»ùÒòÇÃÈëϸ°û ¨C ÍêÃÀÕæÈË    »ùÒòÇÃÈëϸ°û ¨C ÍêÃÀÕæÈË    »ùÒòÇÃÈëϸ°û ¨C ÍêÃÀÕæÈË    »ùÒòÇÃÈëϸ°û ¨C ÍêÃÀÕæÈË   

»ùÒòÇÃÈëϸ°û ¨C ÍêÃÀÕæÈË
¹ãÖÝÊÐ»ÆÆÒÇø¿ÆÑ§³ÇÞäȪ·3ºÅ¹ãÖݹú¼ÊÆóÒµ·õ»¯Æ÷D¶°501ÊÒ

Copyright ? 2018 ÍêÃÀÕæÈË All Rights Reserved ÔÁICP±¸17133510ºÅ